Submission guidelines


FREE student registration: ESGCT is thrilled to announce that we will continue to waive the congress registration fee for active student members* who are authors of an abstract accepted for oral or poster presentation. 
* Students must hold an active ESGCT student membership at the dates of the congress 


- To ensure that the best and most current research is presented, a large proportion of the programme is dedicated to selected abstracts. A panel of international moderators reviews the abstracts so that every abstract receives at least 3 reviewer scores.

- All accepted abstracts will be published in our journal, Human Gene Therapy if authors consent to this.


Make sure your abstract is submitted on time and in the right format by following these simple steps:

1: Your abstract should be no more than 250 words in length and should be in English.
2: Abstracts should be continuous text and not split up into subheadings such as "introduction, methods, results".
3: Keep your title concise and informative and only use capital letters for the beginning of a sentence or an acronym/name (sentence case). DO NOT USE CAPITAL LETTERS FOR YOUR ENTIRE TITLE.
4: The names of all authors associated with the abstract must be listed, and a presenting author must be identified. Please note the email address you supplied when submitting your abstract, as it will be used for all correspondence pertaining to the abstract.
5: All authors' names should be listed as initials and surname. Only the first letter of the surname should be capitalised, not the full surname (i.e. JR Smith, not JR SMITH)
6: Addresses should be in the following format: Group, Department/Institute, Organisation, Town/City, Postcode, Country
7: Do not include acknowledgements or references in your abstracts – these will be counted in your word count.
8: Select the subject area that best fits your abstract as this is a guide for review allocation.
9: Please ensure that the email provided when submitting the abstract will still be valid in early-September when the abstract notification is emailed.

What happens after you have submitted?

Your abstract will be sent for review by a panel of international moderators. Every abstract receives at least 3 reviewer scores.

Notification of acceptance

You will be notified of the outcome by email in mid-September. Please note the notification email will be sent to the email given when you submitted your abstract. If you have not received notification by the end of September please contact the ESGCT Office immediately.

Acceptance of Presentation

All notified abstract presenters are required to accept their presentation as instructed in their notification email. 

Late Breaking Abstract Submissions

ESGCT will accept Late Breaking Abstract submissions until the end of August.

Abstract Questions

For all questions regarding the abstract submission process, please contact Gaëlle Jamar.

PLEASE NOTE that all submitting authors will have to have read and agreed to the Abstract Submission Terms & Conditions prior to submission.